Literature DB >> 4352659

Protein kinase activity in erythrocyte ghosts of patients with myotonic muscular dystrophy.

A D Roses, S H Appel.   

Abstract

Myotonic muscular dystrophy is a disorder of humans that involves many organ systems. Physiological studies have suggested that the fundamental defect is of membrane origin. Heretofore, no reproducible metabolic abnormalities have been demonstrated. In the present studies we used erythrocyte ghosts as a convenient source of purified membranes that do not possess changes of denervation, dystrophy, and fibrosis that might complicate the interpretation of muscle membrane changes. Our experiments demonstrated a significant difference in the phosphorylation of erythrocyte ghost protein by [gamma-(32)P]ATP, with endogenous protein kinase of erythrocyte membrane as the enzyme source. After ghosts were kept for 1 week at -20 degrees , phosphorylation of membrane protein in eight controls was twice as high as endogenous protein kinase activity measured in fresh preparations. No stimulation was seen in preparations from seven myotonic dystrophy patients from three different families. This reproducible difference in normal and myotonic membranes may represent an important new approach to studies of this debilitating inborn error of metabolism.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4352659      PMCID: PMC433612          DOI: 10.1073/pnas.70.6.1855

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids.

Authors:  D AMINOFF
Journal:  Biochem J       Date:  1961-11       Impact factor: 3.857

2.  Studies on myotonia. Biochemical and electron microscopic studies on myotonia congenita and myotonia dystrophica.

Authors:  F J Samaha; J M Schroeder; J Rebeiz; R D Adams
Journal:  Arch Neurol       Date:  1967-07

3.  Studies on red-cell ghost ATPase systems: properties of a (Mg2+ + Ca2+)-dependent ATPase.

Authors:  P Wins; E Schoffeniels
Journal:  Biochim Biophys Acta       Date:  1966-07-13

4.  Myotonia atrophica: diagnosis in patient with complete heart block and Stokes-Adams syncope.

Authors:  R J Bache; G A Sarosi
Journal:  Arch Intern Med       Date:  1968-04

5.  A convenient method of preparing polyacrylamide gels for liquid scintillation spectrometry.

Authors:  P V Tishler; C J Epstein
Journal:  Anal Biochem       Date:  1968-01       Impact factor: 3.365

6.  A simple method for the preparation of 32-P-labelled adenosine triphosphate of high specific activity.

Authors:  I M Glynn; J B Chappell
Journal:  Biochem J       Date:  1964-01       Impact factor: 3.857

7.  [Studies on the digestive tract in myotonic dystrophy].

Authors:  E Kuhn; J Schaaf; W Wenz; W Stein
Journal:  Schweiz Med Wochenschr       Date:  1965-09-18

8.  Abnormalities in swallowing associated with dystrophia myotonica.

Authors:  D T Hughes; J C Swann; J A Gleeson; F I Lee
Journal:  Brain       Date:  1965-12       Impact factor: 13.501

9.  The heart in myotonia atrophica.

Authors:  S C Church
Journal:  Arch Intern Med       Date:  1967-02

10.  Erythrocyte abnormality in human myopathy.

Authors:  H D Brown; S K Chattopadhyay; A B Patel
Journal:  Science       Date:  1967-09-29       Impact factor: 47.728

View more
  20 in total

1.  Phosphorylation of casein by human erythrocyte membrane-bound protein kinase: competition of casein with endogenous substrates.

Authors:  J D Vickers; J Brierley; M P Rathbone
Journal:  J Membr Biol       Date:  1979-08       Impact factor: 1.843

2.  Localisation of the myotonic dystrophy locus to 19q13.2-19q13.3 and its relationship to twelve polymorphic loci on 19q.

Authors:  H G Harley; K V Walsh; S Rundle; J D Brook; M Sarfarazi; M C Koch; J L Floyd; P S Harper; D J Shaw
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

3.  Carbohydrate metabolism in dystrophia myotonica.

Authors:  A G Cudworth; B A Walker
Journal:  J Med Genet       Date:  1975-06       Impact factor: 6.318

Review 4.  The muscle cell.

Authors:  J C Sloper; M C Barrett; T A Partridge
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

5.  Electron spin resonance studies of erythrocytes from patients with myotonic muscular dystrophy.

Authors:  D A Butterfield; D B Chesnut; A D Roses; S H Appel
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

6.  Purine metabolism of erythrocytes in myotonic dystrophy.

Authors:  M M Müller; R Kuzmits; M Frass; B Mamoli
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

7.  Lymphocyte capping in myotonic dystrophy.

Authors:  G L Walker; U Karagol; E C Mathieson; R J Lane; F L Mastaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-01       Impact factor: 10.154

8.  Response to controlled ovarian stimulation and oocyte quality in women with myotonic dystrophy type I.

Authors:  Banchhita Sahu; Ozkan Ozturk; Nandita Deo; Karen Fordham; Massimo Ranierri; Paul Serhal
Journal:  J Assist Reprod Genet       Date:  2008-01-18       Impact factor: 3.412

9.  Clinical and electrophysiological observations in patients with myotonic muscle disease and the therapeutic effect of N-propyl-ajmalin.

Authors:  K L Birnberger; R Rüdel; A Struppler
Journal:  J Neurol       Date:  1975-09-01       Impact factor: 4.849

10.  Nifedipine in the treatment of myotonia in myotonic dystrophy.

Authors:  R Grant; D L Sutton; P O Behan; J P Ballantyne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.